文献速递生殖医学

植入前遗传学筛查对美国供卵受体周期的影响

Impact of preimplantation genetic screening on donor oocyte-recipient cycles in the United States.
PubMed 文献 · Am J Obstet Gynecol · 2017-07-20

该回顾性横断面研究分析2005至2013年美国辅助生殖技术临床结局报告系统数据,比较供卵受体周期中植入前遗传学筛查组与对照组的妊娠及活产率。校正患者与供者年龄、移植胚胎数、种族、不孕诊断及周期年份后,筛查组活产校正比值降低35%(OR 0.65,95%CI 0.53-0.80;P<.001)。结论认为过去9年供卵受体周期中实施的植入前遗传学筛查未与活产几率改善或流产率降低相关。

要点

  • 供卵受体周期中,植入前遗传学筛查组妊娠率与活产率均显著低于对照组。
  • 校正后筛查组活产比值降低35%(OR 0.65,95%CI 0.53-0.80;P<.001)。
  • 过去9年供卵受体周期中实施的植入前遗传学筛查未与活产几率改善或流产率降低相关。

核心结论

  • 过去9年供卵受体周期中实施的植入前遗传学筛查未与活产几率改善或流产率降低相关。

研究设计与样本

  • 回顾性横断面研究,分析2005至2013年美国辅助生殖技术临床结局报告系统全国数据。
  • 该系统依赖美国超过90%体外受精中心的年度自愿报告。
  • 评估供卵受体周期中第5/6天胚胎首次移植后的妊娠率与活产率。
  • 比较392个植入前遗传学筛查周期与20,616个对照周期,统计模型校正患者与供者年龄、移植胚胎数、种族、不孕诊断及周期年份。

主要发现

  • 总体上,植入前遗传学筛查周期妊娠率与活产率均显著低于对照周期。
  • 校正后植入前遗传学筛查周期活产比值降低35%(OR 0.65,95%CI 0.53-0.80;P<.001)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Our objective was to estimate the contribution of preimplantation genetic screening to in vitro fertilization pregnancy outcomes in donor oocyte-recipient cycles. STUDY DESIGN: This was a retrospective cross-sectional study of US national data from the Society for Assisted Reproductive Technology Clinic Outcome Reporting System between 2005 and 2013. Society for Assisted Reproductive Technology Clinic Outcome Reporting relies on voluntarily annual reports by more than 90% of US in vitro fertilization centers. We evaluated pregnancy and live birth rates in donor oocyte-recipient cycles after the first embryo transfer with day 5/6 embryos. Statistical models, adjusted for patient and donor ages, number of embryos transferred, race, infertility diagnosis, and cycle year were created to compare live birth rates in 392 preimplantation genetic screening and 20,616 control cycles. RESULTS: Overall, pregnancy and live birth rates were significantly lower in preimplantation genetic screening cycles than in control cycles. Adjusted odds of live birth for preimplantation genetic screening cycles were reduced by 35% (odds ratio, 0.65, 95% confidence interval, 0.53-0.80; P < .001). CONCLUSION: Preimplantation genetic screening, as practiced in donor oocyte-recipient cycles over the past 9 years, has not been associated with improved odds of live birth or reduction in miscarriage rates.

来源:Am J Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Barad DH, Darmon SK, Kushnir VA, et al. Impact of preimplantation genetic screening on donor oocyte-recipient cycles in the United States. Am J Obstet Gynecol. 2017. PMID: 28735705. doi:10.1016/j.ajog.2017.07.023

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。